[go: up one dir, main page]

AU2002254189A1 - Methods of reducing beta-amyloid polypeptides - Google Patents

Methods of reducing beta-amyloid polypeptides

Info

Publication number
AU2002254189A1
AU2002254189A1 AU2002254189A AU2002254189A AU2002254189A1 AU 2002254189 A1 AU2002254189 A1 AU 2002254189A1 AU 2002254189 A AU2002254189 A AU 2002254189A AU 2002254189 A AU2002254189 A AU 2002254189A AU 2002254189 A1 AU2002254189 A1 AU 2002254189A1
Authority
AU
Australia
Prior art keywords
methods
reducing beta
amyloid polypeptides
amyloid
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002254189A
Inventor
Christopher B. Eckman
Abdul H. Fauq
Sharie J. Haugabook
Debra M. Yager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Clinic in Florida
Original Assignee
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Clinic in Florida filed Critical Mayo Clinic in Florida
Publication of AU2002254189A1 publication Critical patent/AU2002254189A1/en
Abandoned legal-status Critical Current

Links

AU2002254189A 2001-03-12 2002-03-12 Methods of reducing beta-amyloid polypeptides Abandoned AU2002254189A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/804,420 2001-03-12

Publications (1)

Publication Number Publication Date
AU2002254189A1 true AU2002254189A1 (en) 2002-09-24

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
AU2002364528A1 (en) Bio-implant and method of making the same
AU2002315166A1 (en) Sir2alpha-based therapeutic and prophylactic methods
AU2002314466A1 (en) Withasol and methods of use
AU2002367147A1 (en) Beta-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
AU2002359694A1 (en) Compounds and methods
AU2002305903A1 (en) Carbohydrate-associated proteins
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2002361763A1 (en) Method of reducing angiogenesis
AU2002241899A1 (en) Tip39 polypeptides
AU2002335667A1 (en) Modified reoviral therapy
PL367329A1 (en) Methods for reducing immunogenicity of polypeptides
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU2002354363A1 (en) Method of activating protein
AU2001100347A4 (en) IFCS firewatch
AU2002351532A1 (en) Method of sampling
AU2002254189A1 (en) Methods of reducing beta-amyloid polypeptides
WO2003016502A9 (en) Tramdorins and methods of using tramdorins
AU2002359898A1 (en) Preparation of alpha-diimines
AU2000280019A1 (en) Polypeptides, methods of making, and uses thereof
AU2002316467A1 (en) Glycosylated kinamycins and methods of making and using them
AU2002324193A1 (en) Therapeutic insert and therapeutic method
AU2002311913A1 (en) Method of use
AU2002318882A1 (en) Novel Method and Structure
AUPR957501A0 (en) Novel method and structure